Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Total revenues $ 4,574 $ 3,519 $ 12,017 $ 9,113
Cost of revenues 1,486 903 4,015 2,636
Gross profit 3,088 2,616 8,002 6,477
Research and development costs 2,630 1,143 6,251 2,774
Sales and marketing expenses 1,826 1,493 5,081 3,916
General and administrative expenses 2,436 1,252 6,062 3,742
Operating loss (3,804) (1,272) (9,392) (3,955)
Other income (expense):        
Other (expense), net 62 (11) (60) (5)
Interest expense, net (238) (201) (809) (1,240)
Net loss $ (3,980) $ (1,484) $ (10,261) $ (5,200)
Net loss per share attributable to common stockholders:        
Basic and diluted $ (180) $ (90.00) $ (500) $ (330)
Weighted average shares used in computing net loss per share:        
Basic and diluted 22,522,460 15,724,401 20,545,080 15,556,231
Product [Member]        
Revenues:        
Total revenues $ 3,338 $ 2,371 $ 8,863 $ 6,186
Service [Member]        
Revenues:        
Total revenues $ 1,236 $ 1,148 $ 3,154 $ 2,927